Olsi Gjyshi retweeted
🗣 calling all #medstudents ‼️🤙
Applying to #RadOnc or interested 🧐 in learning more? ☢️☢️
Sign up for @ACROresident’s #mentorship program 🤝 to get paired 1️⃣:1️⃣ with a #resident of similar interests: acro.org/residents/resident-…
We’d ♥️ to help you! @emily_merfeld @ACRORadOnc – at Houston, TX
Olsi Gjyshi retweeted
@RadOncQuestions' amazing editors ensure our content is clinically relevant & up to date with current #radonc literature. Thanks to #RadBio editor extraordinaire Dr. Shane Stecklein @shanestecklein for overseeing the #radbio content expansion to nearly 500 questions!
.
RTOG-0617 and PO1 highlighted the importance of mitigating cardiopulmonary toxicity in NSCLC. Protons might better spare heart/lung, so we compared IMPT vs. PSPT in LA-NSCLC for toxicity and outcomes. jto.org/action/showPdf?pii=S… @ACKoongMDPhD @PrajnanDasMD @SJFrankMD @liao_zhongxing
IMPT provided favorable dosimetry compared to PSPT in the high-dose, but not low-dose regions for heart, lung, esophagus. IMPT was also associated with lower ≥G3 cardiopulmonary toxicity.
1
3
Suggests IMPT may reduce toxicity without compromising disease control, and it will be interesting to see how it fairs compared to IMRT in upcoming RTOG-1308 and @MDAndersonNews NCT01629498. Individualized modality selection based on tumor anatomy is always key! @ChelseaPinnix
3
Olsi Gjyshi retweeted
Calling all medical students applying in #RadOnc! Join us tomorrow 10/13 from 4:00 - 5:00 pm CST to learn more about our @MDAndersonNews #RadOnc residency program & to meet our incredible faculty! Register here:
mdacc.zoom.us/j/95643768129?…
📢☢️ Register for the @MDAndersonNews #RadOnc info session with faculty (October 13)❗️ #MedEd #MedTwitter @AROPC_org @RadOncPDs @PrajnanDasMD @ACKoongMDPhD @ChelseaPinnix @JillGunther @DrEmmaHolliday 👇🏼
Olsi Gjyshi retweeted
📢#MedEd interested in #RadOnc ☢️ @MDAndersonNews #RO #Residency Info Sessions on 9/23 (with residents) and 10/13 (with faculty) ... Register here for the 9/23 session 👇🏽👇🏽👇🏽 mdacc.zoom.us/meeting/regist… @JillGunther @ChelseaPinnix @DrEmmaHolliday
Olsi Gjyshi retweeted
ASCENDE-RT ⬆️GU tox w BT but ⬆️PSA control...
Option #1: give up on BT
Option #2: improve on BT tech
MARS - pubmed.ncbi.nlm.nih.gov/3268…
Dose to EUS matters
@SJFrankMD @daniel_petereit @PeteRossiMD @brettcoxmd @TimShowalter1 @DrBMoran
Olsi Gjyshi retweeted
spread the word, will soon send the zoom link. our first ILROG webinar, with our guest speaker Prof. Engert with an update on HD 17. @ASH_hematology @ASCO @ARRO_org @ASTRO_org @ILROGTeam @LLSusa @MDAndersonNews
Olsi Gjyshi retweeted
The HPV vaccine is most effective in preventing cancer when given between the ages of nine and 14.
Our Dr. Lois Ramondetta and Dr. Michael Roth discuss how to get your kids safely vaccinated during COVID-19: https://teapawt.net/t.co/eZKUVQNFng @MRoth_MD @DrRamondetta #COVID19 #EndCancer
Is PCI beneficial for patients with extensive stage SCLC? The answer remains elusive and here we look at recent practice patterns in the US.
@ebludmir @StevenLin_MDPhD @PrajnanDasMD jamanetwork.com/journals/jam…
















